Targeting Tumor Metabolism: A New Challenge in Improving Immunotherapy
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: closed (10 July 2023) | Viewed by 159
Special Issue Editor
2. Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
Interests: cancer metabolism and nutrition; clinical nutrition; oncology; surgery
Special Issue Information
Dear Colleagues,
Recent clinical trials have shown promising results in immunotherapy for cancer treatment. However, cancer immunotherapy is suitable for only a small percentage of cancer patients. To expand the patient population that can be benefit from tumor immunotherapy, it is essential to understand the key mechanisms that generate the immunosuppressive tumor microenvironment (TME).
We invite authors to submit studies on cancer immunotherapy or comprehensive review summaries of exciting new advances in the field.
This Special Issue aims to shed light on cancer metabolism, with a special focus on immunotherapy, for researchers, clinicians, and physicians who are interested in cancer immunotherapy.
Dr. Hanping Shi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oncology
- metabolism
- immunotherapy
- immune checkpoints
- metabolic checkpoints
- tumor cell metabolism
- tumor microenvironment
